Reports stated that CHE efficiently enhanced the drug sensitivity of NSCLC cell lines (including cisplatin-resistant A549) to cisplatin by inhibiting the expression of PKC-α and elevating tumor cell apoptosis rates (Gao et al., 2007). This evidence concerns the gene PRKCA and neoplasm.